Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Fidia Spa ( (IT:FDA) ) is now available.
Fidia S.p.A. announced the conversion of five bonds into 208,333 new shares at a price of Euro 0.24 per share, as part of a convertible bond loan with warrants reserved for GGHL. This conversion increases the company’s share capital by Euro 50,000, bringing the total to Euro 7,547,761.90, with 13,660,718 shares now in circulation. This move reflects Fidia’s strategic financial maneuvers to enhance its market position and operational capacity.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in San Mauro Torinese, is a global leader in designing, producing, and marketing high-performance integrated milling systems. The company primarily serves the automotive and aerospace sectors, offering comprehensive solutions for the entire milling process. With over 40 years of experience and approximately 135 employees, Fidia specializes in numerical controls, high-speed milling systems, and CAM software for complex shapes.
Average Trading Volume: 420,951
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.94M
For an in-depth examination of FDA stock, go to TipRanks’ Overview page.